← Companies|Vectura (PMI)
Ve

Vectura (PMI)

Chippenham UKFounded 2007500 employees
Private CapbiotechAcquiredRespiratory
Platform: Inhaled CDMO
Market Cap
N/A
All Drugs
3
Clinical Trials
8
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (3 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
VEC-8813VEC-8813Phase 34Cell TherapyJAK2SOS1iMCCCrohn's
LirazasiranVEC-5287Phase 32Bispecific AbKRASG12DKRASG12CiHemophilia ACF
VEC-6874VEC-6874Phase 2/32Bispecific AbTauRAS(ON)iFL
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (11)
2025-07-13
VEC-8813 NDA
Crohn's
Past
2026-03-06
VEC-8813 Ph3 Readout
Crohn's
Past
2026-05-02
VEC-8813 BTD
MCC
BTD
2026-10-22
VEC-8813 Ph3 Readout
UC
Ph3 Readout
2026-12-21
VEC-6874 Ph1 Dose Esc
FL
Ph1 Dose Esc
2027-04-21
VEC-8813 Ph3 Readout
MCC
Ph3 Readout
2029-01-21
VEC-6874 Ph3 Readout
FL
Ph3 Readout
2029-07-14
Lirazasiran Ph3 Readout
Hemophilia A
Ph3 Readout
2030-05-12
VEC-8813 Ph3 Readout
Crohn's
Ph3 Readout
2031-06-13
VEC-6874 Ph3 Readout
FL
Ph3 Readout
2031-10-07
Lirazasiran Ph3 Readout
CF
Ph3 Readout